Shopping Cart
Remove All
Your shopping cart is currently empty
Vonlerizumab
(Synonyms: Anti-TNFRSF4/OX40/CD134 Antibody) Copy Product Info
🥰Excellent
Synonyms: Anti-TNFRSF4/OX40/CD134 Antibody
Catalog No. T77368 Copy Product Info
🥰Excellent
Vonlerizumab (Anti-TNFRSF4/OX40/CD134 Antibody) is a humanized monoclonal antibody that specifically targets TNFRSF4/OX40/CD134. As an OX40 agonist, vonlerizumab promotes the proliferation of effector T cells and suppresses the function of regulatory T cells by binding to and activating the OX40 receptor on the surface of T cells, thereby enhancing the antitumor immune response. Vonlerizumab can be used in cancer immunotherapy research.
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $358 | - | In Stock | |
| 5 mg | $1,120 | - | In Stock | |
| 10 mg | $1,790 | - | In Stock | |
| 25 mg | $3,360 | - | In Stock | |
| 50 mg | Preferential | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:98.93% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Vonlerizumab (Anti-TNFRSF4/OX40/CD134 Antibody) is a humanized monoclonal antibody that specifically targets TNFRSF4/OX40/CD134. As an OX40 agonist, vonlerizumab promotes the proliferation of effector T cells and suppresses the function of regulatory T cells by binding to and activating the OX40 receptor on the surface of T cells, thereby enhancing the antitumor immune response. Vonlerizumab can be used in cancer immunotherapy research. |
| Synonyms | Anti-TNFRSF4/OX40/CD134 Antibody |
| Reactivity | Human |
| Verified Activity | OX40-NF-κB-Jurkat cells at 1×10^5 cell/well can bind Vonlerizumab. The EC50 is 0.008 μg/mL. |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | TNFRSF4/OX40/CD134 |
| Molecular Weight | 145.22 kDa |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | Store at low temperature -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Preview
Related Tags: Vonlerizumab chemical structure | Vonlerizumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.